145 related articles for article (PubMed ID: 10979335)
1. Gemcitabine-induced severe extremity edema with muscle contractures and subsequent prevention with prednisone.
Geffen DB; Horowitz J
Isr Med Assoc J; 2000 Jul; 2(7):552-3. PubMed ID: 10979335
[No Abstract] [Full Text] [Related]
2. [Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer].
Dahan L; Ressiot E; Cournede A; Ries P; Duluc M; Laquiere A; Laugier R; Braguer D; Seitz JF
Gastroenterol Clin Biol; 2007 Dec; 31(12):1143-5. PubMed ID: 18176375
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of gemcitabine toxicity with a brief course of oral corticosteroid therapy.
Vander Els NJ; Miller V
Chest; 1998 Dec; 114(6):1779-81. PubMed ID: 9872221
[TBL] [Abstract][Full Text] [Related]
4. [A case of pancreatic cancer complicated by gemcitabine-induced peripheral edema].
Shitara K; Ishiguro A; Munakata M; Sakata Y; Hirata N; Yabu K; Wada R
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1981-4. PubMed ID: 16282740
[TBL] [Abstract][Full Text] [Related]
5. Hemolytic-uremic syndrome associated with gemcitabine treatment for metastatic pancreatic cancer.
Boeck S; Geiger S; Schulz C; Heinemann V
J Clin Gastroenterol; 2008; 42(5):551-2. PubMed ID: 18344882
[No Abstract] [Full Text] [Related]
6. Thrombotic microangiopathy with renal failure in two patients undergoing gemcitabine chemotherapy.
Lhotta K; Kühr T; Rumpelt HJ; Wöll E; Thaler J; König P
Am J Nephrol; 1999; 19(5):590-3. PubMed ID: 10575189
[TBL] [Abstract][Full Text] [Related]
7. First case report associating gemcitabine with hypersensitivity reaction in a patient with pancreatic cancer.
Saif MW; Chakerian P; Kaley K; Lamb L
JOP; 2010 May; 11(3):273-4. PubMed ID: 20442527
[No Abstract] [Full Text] [Related]
8. Gemcitabine-induced myositis in a diabetes mellitus patient on hemodialysis.
Chun JY; Lee JM; Ahn DW; Chai JW; Kim YA; Shin K
Korean J Intern Med; 2017 Sep; 32(5):930-932. PubMed ID: 26922072
[No Abstract] [Full Text] [Related]
9. Gemcitabine associated pseudocellulitis.
Singh A; Hampole H
J Gen Intern Med; 2012 Dec; 27(12):1721. PubMed ID: 22696254
[No Abstract] [Full Text] [Related]
10. Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report.
Syrios J; Kechagias G; Xynos ID; Gamaletsou MN; Papageorgiou A; Agrogiannis G; Tsavaris N
BMC Gastroenterol; 2011 Apr; 11():33. PubMed ID: 21470434
[TBL] [Abstract][Full Text] [Related]
11. Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease.
Biswas S; Nik S; Corrie PG
Clin Oncol (R Coll Radiol); 2004 Dec; 16(8):577-9. PubMed ID: 15630853
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine-induced chronic systemic capillary leak syndrome: a life-threatening disease.
Baron D; Mayo A; Kluger Y
Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):90-1. PubMed ID: 16477934
[No Abstract] [Full Text] [Related]
13. Unprecedented case of tumor lysis syndrome in a patient with metastatic pancreatic adenocarcinoma.
Ling W; Sachdeva P; Wong AS; Lee SC; Zee YK
Pancreas; 2012 May; 41(4):659-61. PubMed ID: 22504387
[No Abstract] [Full Text] [Related]
14. Sudden cardio-pulmonary toxicity following a single infusion of gemcitabine.
Ciotti R; Belotti G; Facchi E; Cantù A; D'Amico A; Gatti C
Ann Oncol; 1999 Aug; 10(8):997. PubMed ID: 10509166
[No Abstract] [Full Text] [Related]
15. Gemcitabine-induced hepatitis in a pancreatic cancer patient receiving adjuvant therapy following metastasectomy.
Saadati H; Peccerillo J; Kaley K; Schilsky ML; Saif MW
JOP; 2009 Sep; 10(5):573-5. PubMed ID: 19734642
[No Abstract] [Full Text] [Related]
16. The role of deoxycytidine kinase in gemcitabine cytotoxicity.
van der Wilt CL; Kroep JR; Bergman AM; Loves WJ; Alvarez E; Talianidis I; Eriksson S; van Groeningen CJ; Pinedo HM; Peters GJ
Adv Exp Med Biol; 2000; 486():287-90. PubMed ID: 11783501
[No Abstract] [Full Text] [Related]
17. Gemcitabine-associated thrombotic thrombocytopenic purpura.
Zupancic M; Shah PC; Shah-Khan F
Lancet Oncol; 2007 Jul; 8(7):634-41. PubMed ID: 17613425
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.
Pentsova E; Liu A; Rosenblum M; O'Reilly E; Chen X; Hormigo A
J Neurooncol; 2012 Jan; 106(1):15-21. PubMed ID: 21811892
[TBL] [Abstract][Full Text] [Related]
19. Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas.
Plate JM; Plate AE; Shott S; Bograd S; Harris JE
Cancer Immunol Immunother; 2005 Sep; 54(9):915-25. PubMed ID: 15782312
[TBL] [Abstract][Full Text] [Related]
20. Comparison of standard-dose and low-dose gemcitabine regimens in pancreatic adenocarcinoma patients: a prospective randomized trial.
Sakamoto H; Kitano M; Suetomi Y; Takeyama Y; Ohyanagi H; Nakai T; Yasuda C; Kudo M
J Gastroenterol; 2006 Jan; 41(1):70-6. PubMed ID: 16501860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
